Medtronic plc FY 2026 10-K, explained in plain English
Key financials — as reported
| Total revenue | $36.4B |
| Gross margin | 65.0% |
| Operating income | $6.5B |
| Net income | $4.8B |
| Diluted EPS | $3.73 |
| Cash & equivalents | $1.9B |
| Total assets | $93.0B |
| Long-term debt | $26.2B |
Key takeaway
Medtronic reported $36.4 billion in revenue with a 65% gross margin and $4.80 billion in net income for fiscal 2026.
🔒 4 more takeaways in the full analysis
Beneath the surface
Net debt is substantial: total debt of about $28.1 billion against just $1.95 billion cash leaves net debt near $26.2 billion, far exceeding what the 'cash & equivalents' headline figure alone would suggest.
🔒 3 more insights a headline reader would miss
This is the free preview. The full analysis explains every line item above and includes 7 more findings — plus insider trades, activist stakes, and 8-K events for MDT.
Read the full analysis free Free account · 5 full analyses included · no card required